Go




Your Feedback
Click here for your feedback form
Healthcare Congresses and Results from Clinical Studies
Conference Call to Highlight Key Data Being Presented at the American Diabetes Association’s 66th Scientific Session
Tuesday, June 13, 2006:

James Shannon, M.D., Head of Pharma Development
Ameet Nathwani, M.D., Global Head of Cardiovascular and Metabolic Clinical Development and Medical Affairs
John Glasspool, Global Head of Cardiovascular and Metabolism Business Franchise

Data presented at the Novartis at American Society of Clinical Oncology Annual Scientific Meeting (ASCO) in Atlanta, Georgia
Monday, June 5, 2006:

David R. Epstein, President and CEO, Novartis Oncology

Data presented at the American Society of Hypertension (ASH) in New York
Wednesday, May 17, 2006:

James Shannon, M.D., Head of Pharma Development
Dr. Michael Weber, Department of Medicine, State University of New York, Brooklyn, New York
Peter Sever, MD, International Centre for Circulatory Health, National Heart & Lung Institute, Imperial College London, United Kingdom
Ameet Nathwani, M.D., Global Head of Cardiovascular and Metabolic Clinical Development and Medical Affairs
John Glasspool, Global Head of Cardiovascular and Metabolism Business Franchise

For previous years go into our IR Archive
Share Information
Click here for more information
Novartis.com Teaser Preview Window
IR Quick Services
quick tools teaser
US Investors only
US Investors only
Japanese Investors only
Japanese investors information
Novartis.com home | Contact | Site Map | Help | Privacy Policy
Use of this website is governed by our Terms of Use.
© 2006 Novartis AG